The candidates for the Conservative party leader have been addressed in an open letter by the Cannabis Industry Council, the Cannabis Trades Association, the British Hemp Alliance, and the Scottish Hemp Association.
The development of the UK’s cannabis sector is being hampered by “bureaucratic and antiquated standards,” according to an open letter from the industry to MPs Elisabeth Truss and Rishi Sunak.
If elected as the leader of the Conservative party, UK Secretary of State for Foreign, Commonwealth, and Development Affairs Liz Truss has pledged to repeal all remaining EU regulations by 2023. Truss has specifically stated that she will end EU regulations that restrict the UK’s ability to build its economy.
MP Rishi Sunak, who is now in second place for the position of leader of the Conservative Party, has also vowed to repeal EU rules following Brexit.
The Cannabis Industry Council, the Cannabis Trades Association, the British Hemp Alliance, and the Scottish Hemp Association point out in the open letter to the MPs that the UK holds a leading position in the international cannabis industry, but that this is jeopardised by EU policies that restrict it.
In the letter, the organisations name two policy areas that they believe are being hampered by present EU legislation. The first is the Novel Foods procedure, which the groups claim restricts entry into the UK cannabis market by SMEs and stifles competition.
The second is how the UK chooses which seeds farmers can use to grow industrial cannabis by consulting the EU Plant Variety database. According to the organisations, allowing non-EU seeds under UK policy would promote choice and competition and serve as a “sign of the promise of a Global Britain.”
In the letter, it is urged that “you explore reform of these cumbersome and antiquated laws, which are hindering a potentially dynamic industry in which the UK is currently a world leader.”
The Scottish Hemp Association’s Chair Kyle Esplin stated “Over the last two years the Scottish Hemp Association has been calling for whole plant hemp extracts to be exempt from Novel Foods regulations.”
“It’s the number one issue hindering industry, future domestic production, and consumer satisfaction. Recently, human trials were completed with five different commercial CBD formulations testing for influence on liver function in a placebo-controlled, randomised, crossover design trial.”
“No evidence of physiologically relevant changes in marker of liver and kidney function where detected in standard nutritional supplement doses.”
“Most consumers are shocked to find out that companies are still being required to test their products on animals, for the sale of a hemp product. Regulators need to take a fresh approach and listen to consumer and industry needs. ”
“We welcome this letter being sent with support from across the industry.”
The groups then exhort government officials to start discussions with UK business organisations about changing policies so that doctors might prescribe cannabis to patients, support employment growth and economic development in the nation.
Reference
Price, S., Price, S. and Price, S., 2022. UK cannabis bodies urge PM candidates to reform restrictive EU policy. [online] Cannabis Wealth. Available at: <https://cannabiswealth.co.uk/2022/09/01/uk-cannabis-bodies-pm-reform-restrictive-eu-policy/> [Accessed 2 September 2022].

